Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ista Pharmaceuticals Inc (ISTA) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ista Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 930553.
Total stock buying since 2011: $17,292.
Total stock sales since 2011: $29,107,060.
Total stock option exercises since 2011: $4,577,253.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 0 | $0 | 688,466 | $5,848,199 | 1,036,291 | $4,386,558 |
| 2011 | 4,000 | $17,292 | 2,305,640 | $23,258,861 | 62,667 | $190,695 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-06 | 0 | $0 | 0 | $0 | 200,000 | $250,000 |
| 2012-05 | 0 | $0 | 0 | $0 | 836,291 | $4,136,558 |
| 2012-03 | 0 | $0 | 688,466 | $5,848,199 | 0 | $0 |
| 2011-09 | 0 | $0 | 159,532 | $648,046 | 0 | $0 |
| 2011-08 | 4,000 | $17,292 | 0 | $0 | 0 | $0 |
| 2011-05 | 0 | $0 | 1,713,056 | $18,055,109 | 62,667 | $190,695 |
| 2011-04 | 0 | $0 | 433,052 | $4,555,706 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-06-06 | Anido Vicente Jr (President & CEO) | Option Ex | 200,000 | 1.25 | 250,000 |
| 2012-05-22 | Mitro Thomas A (VP, Sales & Marketing) | Option Ex | 116,804 | 5.27 | 615,323 |
| 2012-05-18 | Mcnamara Timothy (VP Clinical Research & Medical) | Option Ex | 80,669 | 5.22 | 421,414 |
| 2012-05-17 | Garrett Marvin J (Vice President, QC, Compliance) | Option Ex | 174,778 | 4.81 | 839,983 |
| 2012-05-17 | Mcmullin Kirk (VP, Operations) | Option Ex | 108,943 | 5.07 | 552,014 |
| 2012-05-10 | Mcginley Kathleen (VP, HR and Corp. Services) | Option Ex | 77,881 | 5.03 | 391,352 |
| 2012-05-08 | Drazba Brian G. (VP, Finance & CAO) | Option Ex | 33,283 | 4.12 | 137,292 |
| 2012-05-08 | Silvernail Lauren P (Chief Financial Officer) | Option Ex | 145,813 | 5.08 | 740,584 |
| 2012-05-08 | Anido Vicente Jr (President & CEO) | Option Ex | 98,120 | 4.47 | 438,596 |
| 2012-03-15 | Credit Suisse Ag/ | Sale | 437,245 | 8.57 | 3,745,877 |
| 2012-03-14 | Credit Suisse Ag/ | Sale | 28,571 | 8.70 | 248,539 |
| 2012-03-08 | Credit Suisse Ag/ | Sale | 222,650 | 8.33 | 1,853,783 |
| 2011-09-15 | Credit Suisse Ag/ | Sale | 4,322 | 4.07 | 17,603 |
| 2011-09-14 | Credit Suisse Ag/ | Sale | 22,576 | 3.94 | 88,949 |
| 2011-09-13 | Credit Suisse Ag/ | Sale | 78,673 | 4.03 | 317,366 |
| 2011-09-07 | Credit Suisse Ag/ | Sale | 1,400 | 4.10 | 5,739 |
| 2011-09-02 | Credit Suisse Ag/ | Sale | 46,761 | 4.14 | 193,403 |
| 2011-09-01 | Credit Suisse Ag/ | Sale | 5,800 | 4.31 | 24,986 |
| 2011-08-11 | Silvernail Lauren P (Chief Financial Officer) | Buy | 2,500 | 4.29 | 10,725 |
| 2011-08-10 | Drazba Brian G. (VP, Finance & CAO) | Buy | 1,500 | 4.38 | 6,567 |
| 2011-05-10 | Silvernail Lauren P (CFO) | Option Ex | 62,667 | 3.04 | 190,695 |
| 2011-05-06 | Deerfield Private Design International, L.p. | Sale | 285,141 | 10.60 | 3,022,494 |
| 2011-05-05 | Deerfield Private Design International, L.p. | Sale | 110,967 | 10.50 | 1,165,153 |
| 2011-05-04 | Deerfield Private Design International, L.p. | Sale | 1,316,948 | 10.53 | 13,867,462 |
| 2011-04-11 | Laporte Kathleen (Director) | Sale | 216,526 | 10.52 | 2,277,853 |
| 2011-04-11 | Credit Suisse Ag/ | Sale | 216,526 | 10.52 | 2,277,853 |
Insider trading activities including stock purchases, stock sales, and option exercises of ISTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ista Pharmaceuticals Inc (symbol ISTA, CIK number 930553) see the Securities and Exchange Commission (SEC) website.